C57BL/6 and DBA/2 mice present a number of behavioral and neurobiological differences and react in opposite ways to cholinergic drugs. A morphological study during ontogony of brain cholinergic organization of these strains was therefore performed by using acetylcholinesterase pharmacohistochemistry and choline acetyltransferase immunohistochemistry. Cross-sectional areas and rostrocaudal measures of selected brain regions were analyzed. C57 mice were characterized by a lower cholinergic density. This deficit was most pronounced in the striatum, the nucleus basalis of Meynert and the nucleus of the diagonal band of Broca. The observed strain differences were shown to be age-related by using mice aged 20–110 postnatal days. The differentially expressed cholinergic deficit in C57 mice may lead to an approach of the degenerative patterns of cholinergic systems in humans.

Keywords:
C57BL/6 mice, DBA/2 mice, Cholinergic systems, Cell density, AChE pharmacohistochemistry, ChAT immunohistochemistry, Brain ontogeny
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.